Act Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Act Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $147,675 - $211,200	-16,500 Reduced 24.44%	51,000 $513,000
Q1 2022 May 11, 2022	SELL	$10.05 - $22.48 $1.22 Million - $2.72 Million	-121,000 Reduced 64.19%	67,500 $836,000
Q4 2021 Feb 03, 2022	BUY	$17.78 - $33.08 $151,130 - $281,180	8,500 Added 4.72%	188,500 $4.31 Million
Q3 2021 Nov 16, 2021	BUY	$10.93 - $23.55 $191,275 - $412,125	17,500 Added 10.77%	180,000 $3.98 Million
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $1.63 Million - $2.36 Million	162,500 New	162,500 $2.11 Million

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Capital Management, LLC with notifications on news.